Dr Horton Stock Cash And Equivalents
| DHI Stock | USD 145.49 4.11 2.91% |
DR Horton fundamentals help investors to digest information that contributes to DR Horton's financial success or failures. It also enables traders to predict the movement of DHI Stock. The fundamental analysis module provides a way to measure DR Horton's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DR Horton stock.
| Last Reported | Projected for Next Year | ||
| Cash And Equivalents | 4.5 B | 2.5 B |
DHI | Cash And Equivalents |
DR Horton Company Cash And Equivalents Analysis
DR Horton's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current DR Horton Cash And Equivalents | 3.87 B |
Most of DR Horton's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DR Horton is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
DHI Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for DR Horton is extremely important. It helps to project a fair market value of DHI Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since DR Horton's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DR Horton's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DR Horton's interrelated accounts and indicators.
Click cells to compare fundamentals
DHI Cash And Equivalents Historical Pattern
Today, most investors in DR Horton Stock are looking for potential investment opportunities by analyzing not only static indicators but also various DR Horton's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash and equivalents growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of DR Horton cash and equivalents as a starting point in their analysis.
DR Horton Cash And Equivalents |
| Timeline |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, DR Horton has 3.87 B in Cash And Equivalents. This is much higher than that of the Household Durables sector and significantly higher than that of the Consumer Discretionary industry. The cash and equivalents for all United States stocks is 43.35% lower than that of the firm.
DHI Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DR Horton's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DR Horton could also be used in its relative valuation, which is a method of valuing DR Horton by comparing valuation metrics of similar companies.DR Horton is currently under evaluation in cash and equivalents category among related companies.
DR Horton ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, DR Horton's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to DR Horton's managers, analysts, and investors.Environmental | Governance | Social |
DHI Fundamentals
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 50.76 B | ||||
| Shares Outstanding | 329.31 M | ||||
| Shares Owned By Insiders | 10.01 % | ||||
| Shares Owned By Institutions | 84.04 % | ||||
| Number Of Shares Shorted | 6.6 M | ||||
| Price To Earning | 5.10 X | ||||
| Price To Book | 2.17 X | ||||
| Price To Sales | 1.40 X | ||||
| Revenue | 35.46 B | ||||
| Gross Profit | 8.91 B | ||||
| EBITDA | 6.19 B | ||||
| Net Income | 4.8 B | ||||
| Cash And Equivalents | 3.87 B | ||||
| Cash Per Share | 7.08 X | ||||
| Total Debt | 5.09 B | ||||
| Debt To Equity | 0.31 % | ||||
| Current Ratio | 5.24 X | ||||
| Book Value Per Share | 72.12 X | ||||
| Cash Flow From Operations | 4.3 B | ||||
| Short Ratio | 2.40 X | ||||
| Earnings Per Share | 14.48 X | ||||
| Price To Earnings To Growth | 0.60 X | ||||
| Target Price | 167.08 | ||||
| Number Of Employees | 13.45 K | ||||
| Beta | 1.67 | ||||
| Market Capitalization | 47.04 B | ||||
| Total Asset | 32.58 B | ||||
| Retained Earnings | 23.59 B | ||||
| Working Capital | 24.44 B | ||||
| Current Asset | 9.78 B | ||||
| Current Liabilities | 849.2 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.11 % | ||||
| Net Asset | 32.58 B | ||||
| Last Dividend Paid | 1.1 |
About DR Horton Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DR Horton's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DR Horton using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DR Horton based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out DR Horton Piotroski F Score and DR Horton Altman Z Score analysis. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.Note that the DR Horton information on this page should be used as a complementary analysis to other DR Horton's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for DHI Stock analysis
When running DR Horton's price analysis, check to measure DR Horton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DR Horton is operating at the current time. Most of DR Horton's value examination focuses on studying past and present price action to predict the probability of DR Horton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DR Horton's price. Additionally, you may evaluate how the addition of DR Horton to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is DR Horton's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.289 | Dividend Share 1.1 | Earnings Share 14.48 | Revenue Per Share 110.586 | Quarterly Revenue Growth 0.142 |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.